White Papers
The Federal Recreational Hemp Phenomenon
Authored by the team at Digamma Consulting, this whitepaper lays out the full history of cannabis regulations in the US, state by state, law by law.
The Importance of the Human Endocannabinoid System when Developing Therapeutic Cannabis Products
In this whitepaper, scientists from Broughton, a regulatory consultancy currently focused on EU and UK cannabis regulation, discuss the importance of the human endocannabinoid system when developing therapeutic cannabis products.
Using NIR Spectroscopy for In-House Cannabis Potency Testing
The concentration of cannabinoids can not only vary between plants, but also between samples harvested from the same plant, hindering accurate product labeling. High performance liquid chromatography (HPLC) is the current standard industry practice for determining cannabinoid concentration, but this is labor-intensive, time-consuming, and destructive.
The Degradation Pathways of Cannabinoids and How to Manage Them
In this whitepaper, scientists from Broughton, a regulatory consultancy currently focused on EU and UK cannabis regulation, discuss the susceptibility of cannabinoids to degrade and summarize the main degradation pathways of the primary cannabinoid products on the market.
A Summary of the Legal Status and Regulatory Pathways to Market for Cannabinoid Products in the UK Market
This whitepaper provides a summary of the current legislation and regulatory landscape within the cannabinoid market in the United Kingdom (UK) and the activities required to facilitate compliance with the law en route to market.
Understanding Sources of Heavy Metals in Cannabis and Hemp: Benefits of a Risk Assessment Strategy
Penned by heavy metals experts Robert Thomas and Anthony DeStefano, this white paper offers guidance as to which elemental contaminants are worthy of consideration, based on likely sources derived from the cultivation, extraction, processing, packaging, and delivery of cannabis and hemp consumer products.
A Conflicting Personality: Can Hyperaccumulating Plants like Cannabis and Hemp be Realistically Used as a Safe Source of Cannabinoids?
This white paper asks the question of whether hemp, which is predominantly grown outdoors and one of the best plants for soil phytoremediation purposes can realistically be used as a safe source of cannabis medicinal and consumer products?
The Role of ICP-MS in Understanding the Toxicological Link Between Lead Contamination in Cannabis and Hemp Consumer Products and Human Disease
This white paper focuses on the common sources of lead pollution and takes a look at the development of inductively coupled plasma mass spectrometry (ICP-MS) as an analytical tool to monitor a person's blood-lead level that is often used as an indicator of the impact of its toxicity on human health.
Improve ROI with Fast Assessment of Decarboxylation Status in Cannabis and Hemp Extracts
Download this webinar summary to learn more about how to enhance the decarboxylation of cannabis and hemp extracts.
